Aerovate Therapeutics Inc (AVTE) News

Form 425 - Prospectuses and communications, business combinations

Form S-4 - Registration of securities, business combinations

Form RW - Registration Withdrawal Request

Form 425 - Prospectuses and communications, business combinations

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024...

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

Merger to create a company focused on advancing Jade Biosciences’ portfolio of novel therapies that aim to...

Form 8-K - Current report

Form 8-K - Current report